摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[2-(2-{2-[2-(dimethylamino)ethylcarbamoyl]-1-methylimidazol-4-ylcarbamoyl}-1-methylimidazol-4-ylcarbamoyl)-1-methylimidazol-4-yl]-3,4-dihydro-3-methyl-4-oxoimdazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide

中文名称
——
中文别名
——
英文名称
3-[2-(2-{2-[2-(dimethylamino)ethylcarbamoyl]-1-methylimidazol-4-ylcarbamoyl}-1-methylimidazol-4-ylcarbamoyl)-1-methylimidazol-4-yl]-3,4-dihydro-3-methyl-4-oxoimdazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
英文别名
N-[2-[[2-[[2-[2-(dimethylamino)ethylcarbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylimidazol-4-yl]carbamoyl]-1-methylimidazol-4-yl]-3-methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide
3-[2-(2-{2-[2-(dimethylamino)ethylcarbamoyl]-1-methylimidazol-4-ylcarbamoyl}-1-methylimidazol-4-ylcarbamoyl)-1-methylimidazol-4-yl]-3,4-dihydro-3-methyl-4-oxoimdazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide化学式
CAS
——
化学式
C25H30N16O5
mdl
——
分子量
634.617
InChiKey
CUUJYKYQCGGBIE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.1
  • 重原子数:
    46
  • 可旋转键数:
    10
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.32
  • 拓扑面积:
    236
  • 氢给体数:
    4
  • 氢受体数:
    12

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    Antitumor Imidazotetrazines. 41. Conjugation of the Antitumor Agents Mitozolomide and Temozolomide to Peptides and Lexitropsins Bearing DNA Major and Minor Groove-Binding Structural Motifs
    摘要:
    Carboxylic acids derived from the amido groups of the antitumor agents mitozolomide and temozolomide have been conjugated to simple amino acids and peptides by carbodiimide coupling. Solid-state peptide synthesis has been applied to link the acids to DNA major groove-binding peptidic motifs known to adopt alpha-helical conformations. Attachment of the acids to pyrrole and imidazole polyamidic lexitropsins gave a series of potential DNA minor groove- binding ligands. In vitro biological evaluation of a limited number of these novel conjugates failed to demonstrate any enhanced growth-inhibitory activity compared to the unconjugated drugs; sites of alkylation at tracts of multiple guanines were also unaffected. Attachment of additional residues at C-8 of the imidazotetrazines did not perturb the chemistry of activation of the bicyclic nucleus, and biological sequelae can be rationalized by invoking the liberation of a common, diffusible, reactive chemical intermediate, the methanediazonium ion.
    DOI:
    10.1021/jm020936d
点击查看最新优质反应信息

同类化合物

米托唑胺 氰基替莫唑胺 替莫唑胺 N-[4-(2-氟苯甲酰)-1,3-二甲基-1H-吡唑-5-基]-N-甲基苯酰胺 3-(2H3)甲基-4-氧代-3,4-二氢咪唑并[5,1-d][1,2,3,5]四嗪-8-甲酰胺 3-(2-氯乙基)-N-甲基-4-氧代-3,4-二氢咪唑并[5,1-d][1,2,3,5]四嗪-8-甲酰胺 3-(2-氯乙基)-N,N-二甲基-4-氧代-3,4-二氢咪唑并[5,1-d][1,2,3,5]四嗪-8-甲酰胺 3-(2-氯乙基)-4-氧代-3H-咪唑并(5,1-d)-1,2,3,5-四嗪-8-羧酸 3,4-二氢-3-甲基-4-氧代咪唑并[5,1-D]-1,2,3,5-四嗪-8-甲酰胺酸 8-carbamoyl-3-(2,3-dichloropropyl)-[3H]-imidazo[5,1-d]-1,2,3,5-tetrazin-4-one 3-(2-bromoethyl)-8-carbamoyl-[3H]-imidazo[5,1-d]-1,2,3,5-tetrazin-4-one 3-(2-((4-fluoro-2-nitrophenyl)(methyl)amino)ethyl)-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide 3-(prop-2-ynyl)-8-(4-(thiophen-3-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 8-(2,4'-bithiazol-2'-yl)-3-methylimidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(methylsulfinylmethyl)-8-(4-(thiophen-3-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(methoxymethyl)-8-(4-(thiophen-2-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one N,6-dimethyl-4-oxo-3-(2,2,2-trifluoroethyl)-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide 3-(methylthiomethyl)-8-(4-(thiophen-3-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(methylsulfinylmethyl)-8-(4-(thiophen-2-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 8-[4-(1,3-Benzodioxol-5-yl)-1,3-thiazol-2-yl]-3-(methoxymethyl)imidazo[5,1-d][1,2,3,5]tetrazin-4-one N-tert-butyl-2-(3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazin-8-yl)thiazole-4-carboxamide 3-methyl-8-(4-(thiophen-3-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-methyl-8-(4-(thiophen-2-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(methoxymethyl)-8-(4-(thiophen-3-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(methoxymethyl)-8-(4-phenylthiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 8-(4-tert-butylthiazol-2-yl)-3-propargylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one 3-(methylthiomethyl)-8-(4-(thiophen-2-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 8-(4-(4-bromophenyl)thiazol-2-yl)-3-(prop-2-ynyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(methylthiomethyl)-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide 8-(morpholinosulfonyl)-3-(2,2,2-trifluoroethyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 6-methyl-8-(methylsulfonyl)-3-(prop-2-ynyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-methyl-8-(4-phenylthiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 8-(4-ethylthiazol-2-yl)-3-methylimidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 4-oxo-3-(prop-2-ynyl)-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide 8-(methylsulfonyl)-3-(prop-2-ynyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-((methoxymethylthio)methyl)-N-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide 8-[4-(4-methylsulfonylphenyl)thiazol-2-yl]-3-propargylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one N-methyl-4-oxo-3-(2,2,2-trifluoroethyl)-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide 8-(1-methyl-4-(thiophen-2-yl)-1H-imidazol-2-yl)-3-(prop-2-ynyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-methyl-N-(iso-butyl)-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide N,N-dimethyl-4-oxo-3-(2,2,2-trifluoroethyl)-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide 3-(methoxymethyl)-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide 8-(4-tert-butylthiazol-2-yl)-3-(methoxymethyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 8-(morpholinosulfonyl)-3-(prop-2-ynyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(methoxymethyl)-8-(4-(4-(methylsulfonyl)phenyl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-methyl-8-(1-methyl-1H-benzo[d]imidazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one N,6-dimethyl-3-(methylsulfinylmethyl)-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide N-methyl-4-oxo-3-((2,2,2-trifluoroethoxy)methyl)-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide